Literature DB >> 21999152

Sirtuins: multifaceted drug targets.

S P Chakrabarty1, H Balaram, S Chandrasekaran.   

Abstract

Sirtuin (Sir2) proteins being key regulators of numerous cellular processes have been, over the recent past, the subject of intense study. Sirs have been implicated in diverse physiological processes ranging from aging and cancer to neurological dysfunctions. Studies on Sir2s using tools of genetics, molecular biology, biochemistry and structural biology have provided significant insight into the diverse functions of this class of deacetylases. This apart, medicinal chemistry approaches have enabled the discovery of modulators (both activators and inhibitors) of Sir2 activity of diverse chemical structures and properties. The availability of these small molecule modulators of Sir2 activity not only has pharmacological significance but also opens up the possibility of exploiting chemical genetic approaches in understanding the role of this multi-functional enzyme in cellular processes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21999152     DOI: 10.2174/156652411798062412

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  4 in total

1.  Sirtuin Deacetylation Mechanism and Catalytic Role of the Dynamic Cofactor Binding Loop.

Authors:  Yawei Shi; Yanzi Zhou; Shenglong Wang; Yingkai Zhang
Journal:  J Phys Chem Lett       Date:  2013-02-07       Impact factor: 6.475

Review 2.  Targeting p53-MDM2-MDMX loop for cancer therapy.

Authors:  Qi Zhang; Shelya X Zeng; Hua Lu
Journal:  Subcell Biochem       Date:  2014

3.  A proteomic perspective of Sirtuin 6 (SIRT6) phosphorylation and interactions and their dependence on its catalytic activity.

Authors:  Yana V Miteva; Ileana M Cristea
Journal:  Mol Cell Proteomics       Date:  2013-10-25       Impact factor: 5.911

4.  Resveratrol attenuates ischemia/reperfusion injury in neonatal cardiomyocytes and its underlying mechanism.

Authors:  Min Shen; Rui-Xin Wu; Lei Zhao; Juan Li; Hai-Tao Guo; Rong Fan; Yan Cui; Yue-Min Wang; Shu-Qiang Yue; Jian-Ming Pei
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.